Usana Health Sciences Inc
USNA
Market Cap$555.24M
Close$
$44.23
51.6% upside
Current Fair Value
51.6% upsideUndervalued by 51.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $555.24 Million |
|---|---|
| Enterprise Value | $398.63 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $2.2 |
| Beta | 1 |
| Outstanding Shares | 19,049,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 16.06 |
|---|---|
| PEG | -37.22 |
| Price to Sales | 0.65 |
| Price to Book Ratio | 0.97 |
| Enterprise Value to Revenue | 0.45 |
| Enterprise Value to EBIT | 5.58 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Usana Health Sciences Inc
CEO: Kevin Guest